ABANZA has completed a funding round of EUR1.2 million led by the Navarran Government-owned development company SODENA and Clave Capital, an alternative asset investment management company specialised in technology transfer projects (through its UN I+D+i Tech Transfer fund.
Spanish start-up ABANZA develops medical devices and instruments for the arthroscopic soft tissue repair market.
SODENA has invested EUR350,000, and Clave Capital EUR500,000 since 2017.
The round also attracted the interest of national and international industrial investors with knowledge and experience in the sector, adding value to the market access strategy.
